FindTrial
Sign In

Comparison of Ketamine and Bupivacaine in local wound infiltration for postoperative pain in adults undergoing below umbilicus hernia surgery

Comparison of Ketamine and Bupivacaine in local wound infiltration for postoperative analgesia in adults undergoing infraumbilical hernia surgery under spinal anaesthesia - A double blinded hospital based randomized clinical trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074421
Enrollment
60
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ketamine: Once closure begins the patient will receive wound infiltration with 1 mg/kg Ketamine. Control Intervention1: Bupivacaine: Once closure begins the patient will receive wound

Sponsors

Dr Apoorva S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA Grade I-III. 2.Patient undergoing infraumbilical hernia surgery under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patient refusal to give consent 2.ASA Grade more than III 3.Pregnant female patients 4.Patients with history of allergy to the study drug 5.Any contraindication for spinal anaesthesia

Design outcomes

Primary

MeasureTime frame
Comparison of ketamine and bupivacaine after local wound infiltration for postoperative painTimepoint: At 0 min, 15 min and 60 minutes,2, 4,6 ,12 and 24 hours post operatively using visual analogue scale—

Secondary

MeasureTime frame
1.To determine the time for first rescue analgesia. 2.To determine the total amount of analgesic in the first 24 hours post-operatively 3.To determine the adverse effects of the drug, if any Timepoint: Anagesia required in first 24 hours post operatively—

Countries

India

Contacts

Public ContactDr Vandana Gogate

KLE Jawaharlal Nehru Medical College, Belgavi

vandanagogate@gmail.com9844083030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026